Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is to Compare the Efficacy and Safety of Rosuvastatin/Amlodipine Combination
Therapy Versus Atorvastatin/Amlodipine Combination Therapy in Hypertension patient with
Dyslipidemia
Phase:
Phase 4
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Amlodipine Amlodipine, atorvastatin drug combination Atorvastatin Rosuvastatin Calcium